Article Details
Retrieved on: 2021-11-16 14:49:21
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
SEATTLE, Nov. 16, 2021 /PRNewswire/ -- Kineta, Inc., a clinical stage biotechnology company focused on the development of novel immunotherapies in ...
Article found on: www.khq.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here